Lönnstedt Ingrid M, Caramia Franco, Li Jason, Fumagalli Debora, Salgado Roberto, Rowan Andrew, Salm Max, Kanu Nnennaya, Savas Peter, Horswell Stuart, Gade Stephan, Loibl Sibylle, Neven Patrick, Sotiriou Christos, Swanton Charles, Loi Sherene, Speed Terence P
Genome Biol. 2014 Oct 1;15(9):470. doi: 10.1186/s13059-014-0470-7.
Intra-tumor heterogeneity concerns the existence of genetically different subclones within the same tumor. Single sample quantification of heterogeneity relies on precise determination of chromosomal copy numbers throughout the genome, and an assessment of whether identified mutation variant allele fractions match clonal or subclonal copy numbers. We discuss these issues using data from SNP arrays, whole exome sequencing and pathologist purity estimates on several breast cancers characterized by ERBB2 amplification. We show that chromosomal copy numbers can only be estimated from SNP array signals or sequencing depths for subclonal tumor samples with simple subclonal architectures under certain assumptions.
肿瘤内异质性涉及同一肿瘤内基因不同的亚克隆的存在。异质性的单样本定量依赖于整个基因组染色体拷贝数的精确测定,以及对已鉴定的突变变异等位基因频率是否与克隆或亚克隆拷贝数相匹配的评估。我们使用来自单核苷酸多态性(SNP)阵列、全外显子测序的数据以及对几种以ERBB2基因为特征的乳腺癌的病理学家纯度估计来讨论这些问题。我们表明,在某些假设下,对于具有简单亚克隆结构的亚克隆肿瘤样本,只能从SNP阵列信号或测序深度估计染色体拷贝数。